Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

STU:BT3 (USA)  
€ 0.83 (+6.45%) Sep 20
At Loss
P/B:
2.60
Market Cap:
€ 159.07M ($ 177.75M)
Enterprise V:
€ 127.21M ($ 142.15M)
Volume:
-
Avg Vol (2M):
50.00
Trade In:

My Checklist

Inactive
Item Name
Rating
Action

Fair Value Votes

Date Voted
Fair Value
Price on Date Voted
% Change Since Voted
% Change Relative to SP500
10/Page
Total 0

My Votes

My Vote : €